Dr. Tenpenny (@BusyDrT)

FDA JUST APPROVED REXULTI AS A TREATMENT FOR ALZHEIMERS even though people prescribed Rexulti faced a fourfold increased risk of dying compared to people who didn’t take the drug, according to an investigation published in the British Medical Journal. Highly Prescribed Drug Gets FDA Green Light Despite 4-Fold Higher Risk of Death https://link.theepochtimes.com/mkt_app/health/highly-prescribed-drug-gets-fda-green-light-despite-4-fold-higher-risk-of-death-5491461